
Atom Computing, Inc.
Pre-revenue deep-tech hardware: sells on-premises full-stack quantum systems to government/enterprise/sovereign buyers and provides cloud access via Microsoft Azure Quantum; revenue today is grants, partnership/co-development, and the first commercial system sales rather than recurring product revenue.
Earnings, margins, COGS & capex
Pre-revenue deep-tech hardware company funded by venture rounds ($5M seed 2018 → $15M Series A 2021 → $60M Series B 2022 → $100M Series C 2026), NSF grants, DARPA/CHIPS government programs, and early commercial system sales (QuNorth/Magne). No income statement, margins, or valuation are publicly disclosed.
Revenue trend
Margins
n/a
n/a
COGS structure
not disclosed
Capex
not disclosed; high by nature — neutral-atom hardware (atom arrays, laser/optics, vacuum, control electronics) and lab/fab scale-up are capital-intensive; the $100M CHIPS LOI is explicitly to scale fabrication.
Latest earnings
n/a
n/a
- Cumulative capital raised
- ~$300M+ (incl. $100M DoC CHIPS LOI), as of Jun 2026
- Series C
- $100M, led by Third Point Ventures (announced 2026-06-16)
- Phoenix physical qubits
- 1,180 (world record); systems now >1,200 physical qubits
- Magne system
- 50 logical / 1,225 physical qubits; targeted commercial Level-2 by end-2026
- Founded / CEO
- 2018, Berkeley CA; CEO Dr. Ben Bloom (co-founder w/ Jonathan King)
Growth drivers
- Magne / QuNorth flagship delivery and follow-on sovereign on-prem system sales
- Microsoft Azure Quantum cloud distribution and co-developed software
- U.S. government funding (CHIPS LOI, DARPA QBI) scaling toward tens of thousands of qubits
- Error-correction / logical-qubit progress unlocking commercial fault-tolerant utility (chemistry, materials, pharma)
Bull & bear
A credible neutral-atom contender with a tier-1 strategic partner (Microsoft), a flagship sovereign deployment (Magne/QuNorth), demonstrated error correction, and U.S. government backing — positioned on the fastest-scaling qubit modality at the point where the industry pivots from physical-qubit records to logical-qubit utility.
- Real fault-tolerance progress: only the second company industry-wide — and first in neutral-atom — to publicly demonstrate full quantum error correction (per 2026-06-16 release), the metric that now matters more than raw qubit count.
- Microsoft is a deep co-development partner, not just a cloud reseller: it integrates its software/middleware and the joint Magne system (50 logical / 1,225 physical qubits) targets being the world's first commercially available 'Level 2' fault-tolerant machine by year-end 2026 — distribution + validation from a hyperscaler.
- Anchor sovereign customer + non-dilutive capital: Denmark's QuNorth (EIFO + Novo Nordisk Foundation, €80M) is buying Magne, and a $100M U.S. DoC CHIPS LOI plus DARPA QBI Stage B participation de-risk the path and signal government strategic backing.
- Neutral-atom is the fastest-scaling modality — 1,000+ atom arrays demonstrated, a clear runway toward tens of thousands of qubits — and Atom held the 1,180-qubit Phoenix world record and was first past the 1,000-qubit threshold for a universal gate-based system (2023).
- On-premises full-stack sales model fits sovereign/government demand (data-sovereignty, national-lab buyers) that pure cloud players can't serve, and repeat backing from Third Point/DCVC/Cisco across rounds shows investor conviction.
A pre-revenue, capital-light-by-quantum-standards startup ($300M cumulative vs. multi-billion-funded rivals) on an unproven timeline, dependent on Microsoft for software/distribution, in a brutally competitive neutral-atom field where the bigger-funded and public comps already trade on minimal revenue — classic early-and-speculative, with the bear holding the edge.
- No disclosed product revenue and no disclosed valuation: the business runs on grants, one commercial system sale, and partnership funding; fault-tolerant commercial utility is still a roadmap item ('by end of 2026'), and quantum timelines routinely slip.
- Undercapitalized relative to the field: $300M cumulative is small next to Pasqal (€340M at ~$2B, Mar 2026), Quantinuum (now public), QuEra (Google-backed $230M, 2025), PsiQuantum and IBM/Google internal programs — a capital-intensive hardware race the company could lose on balance-sheet alone.
- Heavy Microsoft dependency cuts both ways: Microsoft controls the software stack, cloud distribution, and the Magne customer relationship, and also partners with QuEra and runs its own topological program — Atom is one of several interchangeable hardware suppliers, not the indispensable partner.
- Crowded neutral-atom subsegment (QuEra, Pasqal, Infleqtion, planqc) plus cross-modality rivals (IonQ ~$19B/$130M rev, Quantinuum, IBM, Google) means even technical wins may not translate to share; the public pure-plays show massive caps on near-zero revenue, i.e. the whole category is priced on hope.
- Binary, milestone-driven risk: value hinges on Magne shipping and working on schedule and on error-correction scaling — a single missed milestone or a rival's logical-qubit breakthrough can re-rate the whole story, and as a private name there's no liquidity to exit.
What it is worth
Venture comparables / last-round + sector multiples (no public price, minimal disclosed revenue → revenue multiples are not meaningful; anchored to the Jun-2026 Series C and neutral-atom/pure-play comps).
A missed Magne milestone, a sector funding winter, or a rival logical-qubit breakthrough compresses the mark toward (or below) invested capital (~$300M); as an illiquid private name, downside is hard to exit.
Implied Series C post-money not disclosed. Triangulating off neutral-atom comps (Pasqal ~$2B at €340M; the smaller $100M Series C round size and ~$300M cumulative capital) suggests a base-case post-money plausibly in the ~$0.5B–1.5B range — UNVERIFIED, inferred, not disclosed by the company.
Re-rates toward Pasqal/IonQ-style multi-billion levels if Magne ships on time as the first commercial Level-2 machine and error correction scales — a >$2B private mark or IPO becomes conceivable.
All ranges are analyst inference from comparables, NOT a disclosed valuation. Company has not published a post-money figure; treat the Series C size and cumulative-capital figures as the only hard anchors.
SWOT
Strengths
- First neutral-atom company to publicly demonstrate full quantum error correction; second industry-wide (2026-06-16).
- Held the 1,180-qubit Phoenix world record; first past 1,000 qubits on a universal gate-based system (2023).
- Deep Microsoft co-development + Azure Quantum distribution; joint Magne 'Level 2' system.
- Long atom coherence-time pedigree (100-qubit gen-1 had ~40s world-record coherence).
- Government/strategic validation: $100M DoC CHIPS LOI, DARPA QBI Stage B, NSF grants.
Weaknesses
- Pre-revenue; no disclosed product revenue, margins, or valuation.
- Undercapitalized vs. neutral-atom and cross-modality rivals (~$300M cumulative).
- Dependent on Microsoft for software stack, cloud, and the anchor customer relationship.
- Capital-intensive hardware burn with a long, uncertain commercialization timeline.
- Concentration on a single flagship deployment (Magne/QuNorth) for near-term proof.
Opportunities
- First commercially available fault-tolerant ('Level 2') machine if Magne ships on time (end-2026).
- Sovereign/government on-prem demand (national labs, defense, data-sovereignty buyers).
- Scale-up to tens of thousands of qubits using CHIPS-backed neutral-atom fabrication.
- Chemistry/materials/pharma use cases via Novo Nordisk Foundation–backed QuNorth.
- A future IPO or strategic acquisition as quantum pure-plays access public markets (Quantinuum, Infleqtion precedents).
Threats
- Better-funded rivals (Pasqal, QuEra/Google, Quantinuum, IBM, Google, IonQ) out-scaling or out-commercializing.
- Microsoft re-weighting toward QuEra or its own topological qubits.
- Quantum-timeline slippage triggering a funding/sentiment winter for the whole sector.
- Public pure-plays' high-multiple/low-revenue dynamic inviting a category-wide de-rating.
- Error-correction or fidelity breakthrough by a competing modality leapfrogging neutral atoms.
Moats, dependencies & bottlenecks
Moats
First neutral-atom QEC demo is a real technical lead, but rivals (QuEra, Pasqal) are close and the field moves fast — a milestone edge, not a structural one.
Powerful distribution and validation, but Microsoft is non-exclusive (also partners QuEra; runs its own topological program) — partner-dependent, not owned.
Sticky national-security/sovereign buyers and federal funding are hard for rivals to displace once embedded, but still early and concentrated.
Deep neutral-atom expertise (long coherence times, scalable arrays); valuable but diffusing across a competitive academic/industry field.
Dependencies
partner / distribution / software Software stack, Azure Quantum cloud, and the Magne customer relationship run through Microsoft, which is non-exclusive and backs competitors.
funding / customer $100M LOI is non-binding; federal funding is policy- and appropriations-dependent.
Near-term commercial proof concentrated in a single flagship deployment with a hard end-2026 date.
optics, vacuum, control electronics) Neutral-atom systems depend on niche photonics/vacuum components with limited vendor pools.
Pre-revenue and cash-burning in a capital-intensive race; future funding depends on sector sentiment and milestone delivery.
Bottlenecks
- Logical-qubit error rates / fidelity scaling — turning the QEC demo into reliably useful fault-tolerant computation at 50+ logical qubits.
- Manufacturing scale-up — moving from lab systems to repeatable on-prem deliveries (the explicit purpose of the CHIPS LOI).
- Capital depth — out-raising/keeping pace with far better-funded neutral-atom and cross-modality rivals.
- Timeline execution — Magne's end-2026 ship date is the single near-term credibility gate.
- Software/middleware dependence on Microsoft for the full-stack user experience.
Top signals & trends
Top signals
Repeat lead (Third Point also led the 2022 Series B) and a strategic (Cisco) signal conviction; LOI is non-dilutive.
QEC is the gating capability for fault tolerance — the metric the field now rewards over raw qubit count.
A named, funded (€80M) sovereign customer and a hard ship date — but the date is the risk too.
Independent government benchmarking validation and a path to further federal funding.
Pre-revenue deep-tech; investors are underwriting a roadmap, not a P&L.
Capital depth often decides capital-intensive hardware races independent of technical merit.
Distribution asset and dependency risk at once; Atom is one of several interchangeable hardware suppliers.
Frothy comps could lift a future Atom round/IPO — or de-rate the entire sector if sentiment turns.
Trends
Plays to Atom's QEC demo and the Magne 'Level 2' positioning — the metric of merit has shifted toward where Atom invested.
Validates the technology bet but intensifies competition and capital pressure within Atom's own modality.
Opens a future liquidity/IPO path and lifts comparable valuations — but exposes under-commercialized names to a reset.
Non-dilutive capital and anchor demand favor full-stack on-prem players like Atom.
Microsoft and Google back multiple horses and run internal programs, capping any single startup's strategic indispensability.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Strategic investor via Cisco Investments (Series C); networking/quantum-data-center interconnect partner.
Partner for hybrid quantum-classical (GPU) integration referenced in coverage of the Series C.
Neutral-atom hardware depends on specialized lasers, optical-tweezer systems, and vacuum/cryo-adjacent components (suppliers not individually disclosed).
Danish entity (EIFO + Novo Nordisk Foundation, €80M) buying the 50-logical-qubit Magne system — Atom's flagship on-prem commercial customer.
Co-funder of QuNorth; signals pharma/chemistry/materials end-use demand for fault-tolerant compute.
Department of Commerce (CHIPS R&D Office) Signed $100M non-binding LOI to scale neutral-atom hardware — government customer/sponsor.
Quantum Benchmarking Initiative (Stage B) — government program participant and validator.
Closest neutral-atom rival; Google-backed ($230M, 2025) and also a Microsoft partner — directly contests Atom's modality and its key partner.
French neutral-atom leader; raised ~€340M at ~$2B (Mar 2026), 200-qubit Aramco/sovereign deployments — far better capitalized in the same modality.
Trapped-ion full-stack leader (Honeywell/Cambridge Quantum); recently IPO'd, resetting valuation/commercialization bar for all pure-plays.
Largest pure-play (~$19B cap, ~$130M 2025 rev, 2026 guide $260-270M); trapped-ion, hyperscaler distribution, SkyWater acquisition — the commercialization benchmark.
Superconducting roadmap leader with deep balance sheet and enterprise reach; cross-modality competition for fault-tolerant utility.
Willow superconducting program plus a stake in QuEra — competes both directly and through its neutral-atom investment.
Superconducting pure-play (~$7B cap, ~$7M 2025 rev); a public-comp valuation reference more than a head-to-head threat.
Neutral-atom/quantum-sensing peer; listed on NYSE (Feb 2026) — same modality, now public.
Photonic fault-tolerance bet, multi-billion-funded; competes for the same 'first useful fault-tolerant machine' narrative.